Mixiii Biomed 2017: Only 7 days left to enter the Competition

  Only 7 days left to register to MIXiii Biomed 2017 Start-up Area and Competition by: Israel Innovation Authority! For competition details please click here. Competition registration deadline: 10 APRIL 2017 REGISTER NOW   Join the road to success and grab the chance to be an active participant at MIXiii BIOMED 2017! As a registered participant […]

BiolineRx buys UK co Agalimmune

BiolineRx buys UK co Agalimmune   23 Mar, 2017 14:29 Gali Weinreb BiolineRx is paying $6 million upfront for Agalimmune, which has developed a new immunotherapy solution for treating cancer. BiolineRx Ltd. (Nasdaq: BLRX); TASE:BLRX) has announced the acquisition of Agalimmune Ltd., a private UK-based company with an innovative, anti-cancer immunotherapy platform. BiolineRx is paying […]

Digital Medicine: the new Israeli invention

  Цифровая медицина: новые изобретения израильтян Производство электронных медицинских приборов стало одной из перспективных отраслей израильского хай-тека. В 2016 году местные фирмы, создающие их, привлекли 183 миллиона долларов в свои разработки. Это следует из отчета компании «Start-UP national central», который был представлен в преддверии открытия израильской технологической конференции Mixiii Biomed 2017. В нашей стране она […]

Israel digital health investments jump 30% in 2016 (English and Hebrew versions)

Some 385 companies operate in the field, with personal health tools and analytics leading deal volume BY SHOSHANNA SOLOMON March 28, 2017   Israel’s digital health sector grew significantly in 2016, both in terms of funding and in terms of the number of companies, with investments jumping almost 30 percent to $183 million in 2016 […]

Ophthalmic device co EyeYon Medical raises $6.5m

21 Mar, 2017 13:53 Globes correspondent China-based venture capital fund Rimonci Capital and co-investor Gauss Group led the financing round. Israeli ophthalmic device co EyeYon Medical founded by ophthalmologists Dr. Arie Marcovich and Dr. Daphna Ofer, and managed by CEO Nahum Ferera, has raised $6.5 million. The company, which emerged from the Val Leer incubator, […]

IBM Watson Health To Integrate MedyMatch Technology Into Cognitive Imaging Offerings To Help Doctors Identify Head Trauma And Stroke

MedyMatch Application to Help Doctors Identify Head Trauma and Stroke MedyMatch Technology recently announced a collaboration with IBM Watson Health to bring MedyMatch’s A.I.-based clinical decision support application to imaging experts working in hospital emergency rooms and other acute care settings to help doctors identify instances of intracranial bleeding as a result of head trauma […]

Mixiii Biomed 2017 Preliminary Program

  PRELIMINARY PROGRAM MIXiii Biomed 2017 – The time for Israel International Innovation is Now! CONFERENCE TRACKS The moment we have all been waiting for is finally here. MIXiii Biomed 2017 is officially opening its doors, offering you a most unique conference experience.The Preliminary Conference Program is now online for you to View with ten main tracks […]

Intermountain taps Zebra Medical Vision to apply deep learning to medical imaging

Imaging analytics promise to change the practice of radiology, an Intermountain official says. By Bernie Monegain March 16, 2017 Intermountain Healthcare is working with Zebra Medical Vision, a deep learning imaging analytics company, based in Israel to integrate machine learning in medical imaging analysis. The goal is to provide better patient care. Here’s how it […]

MIXIII BIOMED 2017: Call for Company presentations

  Call for Abstracts / Oral Company Presentations This is your Chance to take the Stage and Speak at Mixiii Biomed 2017!!! Don’t miss this opportunity to participate- Submission Deadline is April 10, 2017! We hereby invite you to take an Active Role by submitting a Company Presentation Abstract to one of the track categories in the MIXiii Biomed […]

FDA fast tracks Israeli co PolyPid

PolyPid is developing a localized delayed release antibiotic for treatment of bone infections. Israeli company PolyPid Optimized Therapeutics, which is developing a localized delayed release antibiotic for treatment of bone infections, has announced its acceptance to the US Food and Drug Administration (FDA) Qualified Infectious Disease Program (QIDP). QIDP is a fairly new FDA status […]